Day: July 4, 2022

These results demonstrate that inhibiting CHI3L1 can restore NK cell activity and boost Trastuzumab (ADCC) efficacy inside a robust preclinical magic size closely mimicking the human being disease. Important for the clinical relevance of this work, is Fludarabine (Fludara) our finding that sera from two cohorts of trastuzumab resistant individuals contained high levels of CHI3L1 […]